AIXIAL GROUP
Aaron De Mello is a seasoned business development professional with extensive experience in the clinical research and pharmaceutical sectors. Currently serving as Senior Director of Business Development at AIXIAL GROUP, Aaron is focused on developing therapies for oncology, cell & gene, and rare diseases. Previous roles include Senior Director of Business Development at Allucent and Associate Key Account Director at IQVIA, where leadership was key in managing real-world offerings for pharmaceutical clients in the NEMEA region. Aaron’s career also features significant positions at PAREXEL, Covance, SynteractHCR, Richmond Pharmacology, CPRS Group, ProClinical, and Barrington James, illustrating a consistent trajectory of increasing responsibility in business development and consultancy. Aaron holds a degree from Solent University and completed early education at Kent College, Canterbury.
This person is not in any teams
This person is not in any offices
AIXIAL GROUP
2 followers
Bringing reliability and expertise to clinical development. Aixial Group is a specialized clinical development partner with the commitment, expertise, and flexibility needed to deliver efficient clinical trials. Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform. For more information, please visit: aixialgroup.com Service Delivery Models: • End to End Clinical Trial Services • Functional Service Provider (FSP) Model • Business Process Outsourcing (BPO) Model • Expert Consulting & Advice • Resourcing & Staffing